Federal Awards

Brugarolas, James, NIH, Evaluation of BAP1 Tumor Suppressor Gene in Renal Cell Carcinoma, $296,932; Carroll, Thomas, NIH, Interactions Between Stroma and Progenitor Cells During Kidney Development, $311,242; Chen, Chuo, NIH, Asymmetric Synthesis of Biologically Active Marine Natural Products, $269,838; Cleaver, Ondine, Maine Med Ctr Res Inst/NIH, Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis, $273,378; Cobb, Melanie (Fellow M. Kalwat), NIH, Role of Isoxazole Compounds in Beta Cell Differentiation and Function, $56,042; Garg, Abhimanyu, NIH, Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients, $327,289;

Gatson, Joshua, Meso Scale Diagnostics/Dept of Defense, Fieldable Multiplex Test for TBI Assessment, $96,450; Green, Carla (Felow C. Rosenweig), NIH, Investigation of the Spontaneous Circadian Hamster Mutation Theta, $30,812; Gruchalla, Rebecca, Univ of Wisconsin/NIH, ICAC3 – Inner City Asthma Consortium 3, $589,136; Jiang, Jin, NIH, Mechanism of Hedgehog Signal Transduction Across the Plasma Membrane, $288,872; Karp, David, Northrop Grumman/NIH, Chair for Ethics Committee, $33,818; Kavalali, Ege (Fellow D. Crawford), NIH, Role of Spontaneous Neurotransmission in Synaptic Plasticity and Behavior, $56,042;

Konopka, Genevieve, NIH, Functional Dissection of Mammalian Vocal Communication, $343,454; Kowalske, Karen, US DHHS, North Texas Burn Rehabilitation Model System, $383,000; Kramer, Helmut, NIH, Genetics of Endocytic Trafficking in the Drosophila Eye, $363,749; Lee, William, Univ of Michigan/NIH, Drug Induced Liver Injury Network, $3,000; Leitch, Marilyn, Duke Univ/NIH, ACOSOG Admin Coordinating Ctr; Site 119, $2,200; Liou, Jen, NIH, Functions and Regulation of Endoplasmic Reticulum-Plasma Membrane Junctions, $285,847; Minei, Joseph, Univ of Washington/NIH, Policy Relevant U.S. Trauma Care System Pragmatic Trial for PTSD and Comorbidity, $8,075;

Niederkorn, Jerry, NIH, Immunobiology of Corneal Allografts, $357,750; Niederkorn, Jerry, NIH, Immunological Modulation of Ocular Tumor Metastases, $253,953; Nijhawan, Ank, NIH, Reducing Readmissions and Improving Outcomes in HIV-Infected Patients, $173,556; Paulk, Elizabeth, Cornell Univ/NIH, Latino vs. Non-Latino Disparities in Advance Care Planning & EOL Care, $68,844; Raj, Ganesh, Univ of Washington/Dept of Defense, Targeting the Aberrant Androgen Receptor in Advanced Treatment Resistant Prostate Cancer, $124,949; Raj, Ganesh (Fellow Y. Yin), Dept of Defense, Targeting Distinct Immunosuppressive Mechanisms to Achieve Synergy for Prostate Cancer Immunotherapy, $118,173;

Raskin, Philip, Case Western Univ/NIH, Residual Beta Cell Function in Patients with Long-Term Type 1 Diabetes, $52,259; Raskin, Philip, Univ of South Florida/NIH, TrialNet Affiliate Services, $16,655; Rosenberg, Roger, Univ of Washington/NIH, National Alzheimer's Coordinating Center, $26,780; Scherer, Philipp, Maine Med Ctr Res Inst/NIH, Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism and Energy Balance, $32,300; Skapek, Stephen, Indiana Univ/NIH, Ras Tumor SPORE w/Indiana Univ., $192,300;

Sperandio, Vanessa, NIH, Tryptophan Derivatives in EHEC Pathogenesis, $457,451; Terman, Jonathan, NIH, Molecular Mechanisms of Axon Guidance and Neural Connectivity, $357,750; Tiro, Jasmin, Univ of Washington/NIH, Randomized Trial of In-Home Cervical Cancer Screening, $11,664; Wyckoff, Myra, RTI Intl/NIH, NICHD Neonatal Research Network, $23,473; Xiao, Guanghua, Univ of Florida/NIH, Equivalent Partial Correlation Methods for Integrative Genetic Network Analysis, $66,217.

Nonfederal Awards

Amatruda, James, Dana-Farber Cancer Inst/St. Baldrick’s Fdn, Malignant Germ Cell Tumors International Consortium, $172,532; Bowers, Daniel, Baylor Univ/CPRIT, Proton Beam Radiation Therapy vs. Conventional Beam Radiation Therapy, $23,906; Brugarolas, James, CPRIT, Targeting the Undruggable: First-in-Class Inhibitor of the HIF-2 Transcription, $299,797; Carroll, Thomas, CPRIT, Role of the Lats Kinases, $299,749; Castrillon, Diego, CPRIT, Novel Tumorigenic Mechanisms of the LKB1 Tumor Suppressor in Endometrial and Cervical Cancer, $299,562; Collins, James, Aberystwyth Univ/Wellcome Trust Sanger Inst, Flatwork Functional Genomics Initiative (FUGI), $193,304;

Conacci-Sorrell, Maralice, CPRIT, Probing the Non-Canonical Role for Cytosolic Myc in Driving Cancer Progression, $493,669; Copley, Lawson, Texas Scottish Rite Hosp, Integrative Genomic Research for Children with Invasive Staphylococcus Aureus Infections, $72,971; Danuser, Gaudenz, CPRIT, Computational Live Cell Histology, $129,621; Deberardinis, Ralph, CPRIT, Carbamoyl Phosphate Synthase-1: A New Metabolic Liability in Non-Small Cell Lung Cancers, $299,997; Deberardinis, Ralph, V Fdn for Cancer Res, Translational Studies in Lung Cancer Metabolism: Creating New Paradigms in Diagnosis and Therapy, $200,000; Doncic, Andreas, CPRIT, Identifying Principles of Metabolic Signaling Pathway Integration Using Live Single-Cell Imaging, $527,205;

Douglas, Peter, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $500,000; Gerber, David, CPRIT, Randomized Controlled Trial (RCT) of Patient Navigation for Lung Cancer Screening in Urban Safety-Net System, $499,669; Greenberg, Benjamin, Transverse Myelitis Assoc, Pediatric Rare Neuroimmunology Biorepository, $30,000; Husain, Mustafa, Univ of New South Wales, Controlled Trial of Transcranial Direct Current Stimulation as Treatment for Unipolar and Bipolar Depression, $12,508; Jiang, Steve, CPRIT, Pediatric Radiation Oncology with Movie Induced Sedation Effect PROMISE, $225,000; Journeycake, Janna, American Soc of Hematology, Longitudinal Observational Study of Previously Treated Hemophilia Patients (PTPs) Switching Factor Products (ATHN2 – Switching Study), $12,500; Knudsen, Erik, Thomas Jefferson Univ/Pfizer, Determinants of Response to CDK4/6 Inhibitors in Melanoma, $65,885;

Kraus, William, CPRIT, Role of Long Non-Coding RNAs, $299,339; Kraus, William, CPRIT, Role of PARP-1 in Estrogen Receptor Enhancer Function and Gene Regulation Outcomes in Breast Cancers, $292,978; Liu, Yi, CPRIT, DNA Damage-Induced Small Non-Coding RNAs: Mechanisms and Their Role in Cancer, $300,029; Luo, Xuelian, CPRIT, Structural and Functional Analyses of the Spindle Checkpoint, $299,991; Martinez, Elisabeth, CPRIT, Characterization and Pharmacological Targeting of the Oncogenic Activity of Jumonji Demethylase Inhibitor, $299,999; Mason, Ralph, Baylor Univ/CPRIT, Baylor: Targeting Hypoxia in Breast Cancer, $107,960;

Mendell, Joshua, CPRIT, DIS3L2 in Childhood Wilms Tumor: Mechanism to Medicines, $300,000; Olson, Eric (Fellow L. Amoasil), American Diabetes Assoc, Molecular Mechanism that Mimics Exercise and Resists Metabolic Syndrome, $55,432; Pagels, Patti, AAFP Fdn, Expanding Smoking Cessation, $4,000; Patrie, Steven, Natl Multiple Sclerosis Soc, Multiple Sclerosis Biomarker Discovery by Proteoform Network Analysis, $44,000; Punaro, Marilynn, Duke Univ/CARRA, Observational Study of Pediatric Rheumatic Diseases: CARRA Registry, $5,000; Raskin, Philip, Univ of South Florida/Juvenile Diabetes Res Fdn, GLEEVAC, $11,195; Rosen, Michael (Fellow L. Case), Damon Runyon Cancer Res Fdn, Regulation of Integrin Clustering on Supported Lipid Bilayers, $52,000;

Sadek, Hesham, CPRIT, Effect of Chest Radiation Therapy on Postnatal Cardiomyocyte Turnover, $299,045; Shay, Jerry, CPRIT, Development of Therapeutics Targeting Truncated Adenomatous Polyposis Coli (APC), $299,991; Shay, Jerry, Cystic Fibrosis Fdn, Genomic Editing of Normal and CF Human Lung Epithelial Cells, $162,000; Singal, Amit, UT HSC San Antonio/CPRIT, STOP HCC–Evidence-Based Hepatocellular Cancer Prevention Targeting Hepatitis C, $166,247; Singal, Amit, Baylor Univ/CPRIT, Comparative Effectiveness Randomized Controlled Trial of Strategies to Increase HCC, $69,499; Terada, Lance, CPRIT, Targeting Metastatic Pathways, $299,988;

Thomas, Philip, Cystic Fibrosis Fdn, Modulation of RAPP to Increase CFTR Expression, $81,000; Thomas, Philip, US-Israel Binatl Science Fdn, Discovery and Mode of Action Studies of CFTR Modulators Acting on NBD1, $22,435; White, Michael, CPRIT, Cancer Intervention and Prevention Discoveries Program, $798,650; Wolf, Steven, UT System, Regionalized System for Pediatric Quality Improvement in the Emergency Department, $26,786; Word, Ruth (Fellow P. Maldonado), PFD Res Fdn, Effects of Ospemifene and Vaginal Estrogen on the Vaginal Wall, $12,500; Zaki, Hasan, CPRIT, Molecular Mechanism of NLRP12-Mediated Regulation of Colorectal Cancer, $298,366.

Industry-Sponsored Awards (Dollar amounts not available)

Alberts, Mark, Phase 3 Study of Secondary Prevention of Stroke and Prevention of Systemic Embolism Comparing Rivaroxaban 15 mg with Aspirin 100 mg, Covance/Bayer; Chong, Benjamin, Natural History of Disease Activity and Damage in Pts with Cutaneous Lupus Erythematosus (CLE), Biogen; Collins, Robert, Phase 3 Study of Rigosertib vs. Physician's Choice of Treatment for Myelodysplastic Syndrome, PSI Pharma/Onconova Therap; Daniels, James, AdaptResponse Study, Medtronic; Diercks, Deborah, International Registry to Assess Medical Practice with Longitudinal Observation for Treatment of Heart Failure (REPORT-HF), Mapi Group/Novartis; Hill, Joseph, TAC Training, Genentech;

Jain, Mamta, Oral HePatitis C Treatment for Indolent Lymphoma (OPTImal), Gilead Sciences; Jain, Mamta, Phase 3 Study of MK-1439A in HIV-1 Infected Sbjs on Ritonavir-Boosted Protease Inhibitor and Two NRTIs, DrugDev/Merck Sharp & Dohme; Schiller, Joan, TIGER-3: Phase 3, Study or Oral Rociletinib Monotherapy vs. Single-Agent Cytotoxic Chemotherapy, PRA Health Sci/Clovis Oncology; Seikaly, Mouin, Study of Cinacalcet HCl in Ped Sbjs with Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Dialysis, N Amer Pediatric Renal Transplant/Amgen; Zhao, Bo, Feasibility of Open Mask HN Treatment with Surface Imaging, Vision RT.